13F Holdings
中文EN

Merck & Co., Inc.

RAHWAY NJ · SEC CIK 0000310158

2026Q22026Q1 9 earlier quarters 🔒
$526.41M2026Q2 reported value
13Positions
99.8%Top 10 weight · largest 35.8%
3 / 4New / sold out
Reported value over time$526.41M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

PSNL 35.8%
MRNA 30.7%
KYMR 16.8%
AKTS 5.8%
EIKN 4.1%
TRDA 2.4%
STRO 1.7%
ALEC 1.4%
EVAXION BIOTEC 0.7%
VRDN 0.3%

2026Q2 top buys estimated at quarter-end value

TRDA New+$12.80M
STRO New+$9.04M
EVAXION BIOTECH New+$3.76M

2026Q2 top sells estimated at quarter-end value

ENTRADA THERAPEU Sold out-$21.96M
SUTRO BIOPHARMA Sold out-$6.78M
EVAXION BIOTECH Sold out-$4.52M
CARISMA THERAPEU Sold out-$47,880

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
PSNL PERSONALIS INC $188.20M35.75%14,044,943 00.0% — Unchanged
MRNA MODERNA INC $161.64M30.71%2,308,190 00.0% — Unchanged
KYMR KYMERA THERAPEUTICS INC $88.54M16.82%772,165 00.0% — Unchanged
AKTS AKTIS ONCOLOGY INC $30.71M5.83%952,844 00.0% — Unchanged
EIKN EIKON THERAPEUTICS INC $21.75M4.13%1,666,666 00.0% — Unchanged
TRDA ENTRADA THERAPEUTICS INC $12.80M2.43%1,739,768 1,739,768— $12.80M New
STRO SUTRO BIOPHARMA INC $9.04M1.72%272,351 272,351— $9.04M New
ALEC ALECTOR INC $7.13M1.35%3,545,719 00.0% — Unchanged
— EVAXION BIOTECH A/S $3.76M0.71%1,214,126 1,214,126— $3.76M New
VRDN VIRIDIAN THERAPEUTICS INC $1.72M0.33%93,414 00.0% — Unchanged
— XILIO THERAPEUTICS INC $1.02M0.19%105,982 00.0% — Unchanged
— TUHURA BIOSCIENCES INC $45,5010.01%19,445 00.0% — Unchanged
— NEUPHORIA THERAPEUTICS INC $43,8180.01%10,027 00.0% — Unchanged
— ENTRADA THERAPEUTICS INC $00.00%0 -1,739,768-100.0% -$21.96M Sold out
— SUTRO BIOPHARMA INC $00.00%0 -272,351-100.0% -$6.78M Sold out
— EVAXION BIOTECH A/S $00.00%0 -1,214,126-100.0% -$4.52M Sold out
— CARISMA THERAPEUTICS INC $00.00%0 -1,473,240-100.0% -$47,880 Sold out